Pathologic features of prostate cancer found at population-based screening with a four-year interval
BACKGROUND: The currently recommended frequency for prostate-specific antigen (PSA) screening tests for prostate cancer is 1 year, but the optimal screening interval is not known. Our goal was to determine if a longer interval would compromise the detection of curable prostate cancer. METHODS: A cohort of 4491 men aged 55-75 years, all participants in the Rotterdam section of the European Randomized Study of (population-based) Screening for Prostate Cancer, were invited to participate in an initial PSA screening. Men who received that screening were invited for a second screen 4 years later. P... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2001 |
Schlagwörter: | *Population Surveillance / Adenocarcinoma/*immunology/*pathology/prevention & control / Aged / Biopsy / Needle / Europe / Humans / Male / Mass Screening/*methods / Middle aged / Netherlands / Predictive Value of Tests / Prognosis / Prostate-Specific Antigen/*blood / Prostatic Neoplasms/*immunology/*pathology/prevention & control / Time Factors |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27608758 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://repub.eur.nl/pub/9698 |